Key facts
- It has raised $4.7M; the latest was Early Stage VC ($790K) in Apr 2025.
- Notable investors include Wayra, Norte Ventures, Enseada Family Office, VEC Investments, André Kina — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Omni Saúde
- ·The full record, as it builds
Funding rounds
No funding rounds for Omni Saúde are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Omni Saúde
Operator of a pharmacy-independent drug platform intended to work as a balance for the purchase of medicines at any pharmacy in the country. The company offers drug plans with a focus on user experience and offers users simple and instantaneous methods by just taking a photo and uploading the medical prescription to release the balance in the app, enabling patients to reduce health costs by reducing treatment abandonment and worsening of untreated diseases.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2023
- Employees
- 29
- Website
- omnisaude.app/
- Ownership
- Privately Held (backing)
Omni Saúde doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Omni Saúde shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Omni Saúde in its N-PORT filings yet. We sweep new filings monthly.